Aenova Group

Our products and behaviour affect and improve the health and well-being of millions of patients, and their families around the world. Our customers entrust us with the responsibility to deliver life-saving or life-enhancing products. We come to work every day to serve these customers, but ultimately, because we passionately care about their patients. With a planned turnover of around EUR 750 million in the current financial year, the Aenova Group is one of the leading companies in the global pharmaceutical and healthcare industry. The groups portfolio of services covers the entire value chain for the development and production of all...

Soft gelatin capsules,vegetarian softgels,effervescent tablets,solid dose tablets,hard capsules,serialization & packaging,semi-solids,suppositories,liquids and syrups,sterile liquids,vials & ampoules,lyophilization,cytotoxics,high potency,animal health cmo,beta-lactam antibiotics,suppositiries,liquids,semi-solids und solid dose tablets

Aenova group operates in the Pharmaceutical manufacturing industry.

Aenova group's revenue is $894.96m

Aenova group has 501 - 1000 employees.